Bookmark and Share

Books

Books/Monographs

R. Faden and A.I. FADEN (Eds.). Ethical Issues in Public Health Policy: Health, Education and Lifestyle Interventions:  Preface.  Health Educ Mono 6:2, 1978.

K.O. Stumpe, K. Kraft, and A.I. FADEN (Eds.). Opioid Peptides and Blood Pressure Control. Springer-Verlag:  Berlin, Heidelberg, 1989.

P. Weinstein and A.I. FADEN (Eds.). Protection of the Brain from Ischemia. Williams and Wilkins, 1990.

S. Salzman and A.I. FADEN (Eds.), Neurobiology of CNS Trauma, Oxford University Press: New York, 1994.

A.I. FADEN (Ed.). J Neurotrauma, Special Edition on Molecular Neurobiology, 12(5), 1995.

V.A. Sharpe and A.I. FADEN.  Medical Harm:  Historical, Conceptual and Ethical Dimensions of Iatrogenic Illness.  Cambridge University Press: Cambridge, UK, 1998.

E. Pellegrino and A.I. FADEN (Eds), Biomedical Ethics: A Jewish-Catholic Dialogue,Georgetown University Press: Washington, D.C., 1999.

A.I. FADEN (ed).  J Neurotrauma, Special Issue on Apoptosis in Central Nervous System Injury 17, 2000.

A.I. FADEN (ed), NeuroRx, Dedicated issue: Neuroprotection 2004.

Book Chapters

J.W. Holaday, G.L. Belenky, A.I. FADEN, and H.H. Loh. Possible function of b-endorphin. In: Saletu,B. (Ed.), Neuropsychopharmacology.  Pergamon Press: London, pp. 503-514, 1979.

A.I. FADEN and J.W. Holaday. Naloxone reversal of hypotension caused by spinal transection. In:  Way, E.L. (Ed.), Endogenous and Exogenous Opiate Agonists and Antagonists.  Pergamon Press:  London, pp. 483-486, 1980.

J.W. Holaday and A.I. FADEN.  Naloxone improvement of shock pathophysiology: Evidence for opiate receptor involvement. In:  Way E.L. (Ed.), Endogenous and Exogenous Opiate Agonists and Antagonists.  Pergamon Press:  London, pp. 479-482, 1980.

J.W. Holaday and A.I. FADEN.  Endorphin involvement in the pathophysiology of shock and trauma: Therapeutic effects of Naloxone. In:  Biro, Z.S., Kovach, A.G.B., Spiker, J.J., Stoner, H.B. (Eds.), Homeostasis and Injury in Shock,  Akademiai Kiado.  Pergamon Press:  Budapest, pp. 131-141, 1981.

J.W. Holaday and A.I. FADEN.  Naloxone and thyrotropin-releasing hormone have additive effects in reversing endotoxic shock. In:  Takai, H. et al. (Eds.), Advances in Endogenous and Exogenous Opioids.  Pergamon Press:  Oxford, pp. 367-370, 1981.6

J.W. Holaday and A.I. FADEN.  Endorphins and thyrotropin releasing hormone in shock and trauma. In:  Yoshida, M. et al. (Eds.), Advances in Pharmacology and Therapeutics.  Pergamon Press:  Oxford, pp. 45-55, 1982.

A.I. FADEN.  Neuropeptides in shock and neural injury.  In:  Chernow, B., Lake, C.R. (Eds.), The Pharmacologic Approach to the Critically Ill Patient. Williams and Wilkins:  Baltimore, pp. 636-649, 1983.

J.W. Holaday and A.I. FADEN.  Thyrotropin-releasing hormone reverses experimental circulatory shock:  Central and peripheral actions of TRH and analogs. In:  Griffiths, E.C., Bennett, G.W. (Eds.), Thyrotropin-Releasing Hormone.  Raven Press:  Baltimore, pp. 372-373, 1983.

A.I. FADEN.  Pharmacologic therapy in acute spinal cord injury:  Experimental strategies and future directions.  In:  Becker, D.P., Povlishock, J.T. (Eds.), Central Nervous System Trauma Status Report (1985). NINCDS:  Bethesda, MD, pp. 481-485, 1985.

T.K. McIntosh, S. Fernyak, and A.I. FADEN.  Endogenous opioids, opiate receptors and traumatic brain injury.  In:  Progress in Opioid Research.  NIDA Research Monograph Series, pp. 527-530, 1986.

A.I. FADEN and T.K. McIntosh.  Endogenous opioids and central cardiovascular control.  In:  Strober, T. et al. (Eds.), CNS Control of the Heart.  Martinus Nijhoff Publishing:  New York, pp. 123-134, 1987.

A.I. FADEN.  New pharmacologic approaches to the therapy of acute spinal cord injury.  In:  Ghista, D.J. (Ed.), Spinal Cord Injury Medical Engineering. 1987.

A.I. FADEN.  The role of endogenous opioids and opiate receptors in the pathogenesis of CNS injury. In:  Sances, A., Jr. (Ed.), Mechanisms of Head and Spine Trauma. Martinus Nijhoff Publishing:  New York, 1987.

T.K. Mclntosh and A.I. FADEN.  Opiate antagonists in CNS injury.  In:   Pharmacologic Approaches to Recovery from Brain Injuries.  Plenum Press, 1987.

P. Demediuk and A.I. FADEN.  Arachidonic acid metabolites and membrane lipid changes in central nervous system injury. In:  Stein, D., Sabel, B. (Eds.), Pharmacologic Approaches to the Treatment of Brain and Spinal Cord Injury.  Plenum Press, pp. 23-42, 1987.

A.I. FADEN.  Role of TRH and opiate receptor antagonists in limiting central nervous system injury. In:  Waxman, S. (Ed.), Physiological Basis for Functional Recovery in Neurological Disease.  Raven Press:  New York, 47: 531-546, 1988.

A.I. FADEN, R. Vink, and T.K. McIntosh.  Thyrotropin-releasing hormone and central nervous system trauma.  In:  Metcalf, G., Jackson, I.M.D. (Eds.), Thyrotropin Releasing Hormone: Biomedical SignificanceAnn NY Acad Sci, 553: 380-384, 1989.

A.I. FADEN.  Effects of TRH on blood flow, circulatory shock, and CNS injury: Summary of section VIII.  In:  Metcalf, G., Jackson, I.M.D. (Eds..), Thyrotropin Releasing Hormone: Biomedical SignificanceAnn NY Acad Sci, 553: 385-387, 1989.

A.I. FADEN and R. Vink.  Chemical pathobiology of CNS trauma.  In:  Bihari, D., Holaday, J.W. (Eds.), Update in Intensive Care and Emergency Medicine.  Springer-Verlag:  Berlin, 9: 14-21, 1989.

R. Vink, T.K. McIntosh, and A.I. FADEN.  Magnetic resonance spectroscopy and the in vivo characterization of cerebral metabolism following brain injury.  In:  Yearbook of the Encyclopedia of Neuroscience: Neuroscience Year.  Birkhauser:  Cambridge, MA., pp. 51-53, 1989.

R. Vink, T.K. McIntosh, and A.I. FADEN.  Magnesium in CNS trauma.  In:  Yearbook of the Encyclopedia of Neuroscience: Neuroscience Year.  Birkhauser:  Cambridge, MA., pp. 149-151, 1989.

A.I. FADEN.  Opioids, opiate receptors, and central cardiovascular regulation.  In:  Opioid Peptides and Blood Pressure Control. Springer-Verlag:  Berlin, pp. 53-61, 1989.

A.I. FADEN. Role of opiate antagonists in the treatment of stroke. In:  Weinstein, P., FADEN, A.I. (Eds.), Protection of the Brain from Ischemia.  Williams and Wilkins:  Baltimore, pp. 265-271, 1990.

R. Vink, T.K. McIntosh, and A.I. FADEN.  Magnesium in neurotrauma: Its role, and therapeutic implications. In:  Scarpa, P., Carbone, E. (Eds.), Magnesium and Excitable Membranes.  Springer-Verlag:  Berlin, pp. 125-145, 1991.W.K. Doyle, C. Wilmot, K.M. Hall, P.R. Cooper, and A.I. FADEN.  Trauma of the spine and spinal cord. In:  Joynt, R. (Ed.), Clinical Neurology.  J. B. Lippincott Co., Vol. 3, Ch. 47, pp. 1-58, 1991.

A.I. FADEN, P. Weinstein, R. Bakshi, S. Yum, M. Lemke, and S. Graham.  Biochemical changes and secondary tissue injury after brain and spinal cord ischemia.  In:  Bazan, N.G., BRAQUET, P., Ginsberg, M.D.(Eds.), Neurochemical Correlates of Cerebral Ischemia. S. Karger AG, Basel, Ch. 9, pp. 161-181, 1992.

S.S. Panter and A.I. FADEN.  Biochemical changes and secondary injury from stroke and trauma.  Chapter 4. In:  Young, R.R., Delwade, P.J. (Eds.), Principles and Practice of Restorative Neurology.  Butterworths:  New York,  pp. 32-52, 1992.

A.I. FADEN.  Role of opioids in central cardiovascular regulation and dysregulation. In:   Herz, A., Akil, H., and Simon, E.J. (Eds.), Chapter 37.  Handbook of Experimental Pharmacology.  Springer-Verlag:  Berlin, pp. 191-204, 1993.

A.I. FADEN.  Role of opioids in central nervous system injury.  In:   Herz, A., Akil, H., and Simon, E.J. (Eds.), Chapter 43:  Handbook of Experimental Pharmacology. Springer-Verlag:  Berlin,  pp. 325-341, 1993.

A.I. FADEN and S. Salzman.  Experimental pharmacology.  In:  Neurobiology of CNS Trauma.  Oxford University Press:  New York, pp. 227-245, 1994.

A.I. FADEN and S. Salzman.  Neurotraumatology:  Future directions.  In:  Neurobiology of CNS Trauma.  Oxford University Press:  New York, 1994.

T.K. McIntosh and A.I. FADEN.  Endogenous opioid peptides and traumatic central nervous system injury.  In:  Neurobiology of CNS Trauma.  Oxford University Press:  New York, 1994.

A.I. FADEN.  Pharmacotherapeutic treatment approaches for brain and spinal cord trauma.  In:  Neurotrauma.  (R. Narayan, J. Wilberger, and J. Povlishock, eds.).  McGraw-Hill:  New York,  11:1479-1490, 1996.

A.I. FADEN.  Therapeutic approaches to spinal cord injury.  In::  Seil, F.J. (Ed.),  Lippincott-Raven Publishers:  Philadelphia, Vol. 72; Ch. 35, pp. 377-386, 1997.

R. Vink, T.K. McIntosh and A.I. FADEN.  Brain injury:  metabolic aspects using magnetic resonance.  In::  Encyclopedia of Neuroscience on CD ROM, 2nd ed.(G. Adelman and B. Smith, eds.).  Elsevier:  New York, 1997.

A. Yakovlev and A.I. FADEN.  Traumatic brain injury regulates expression of Ced-related genes modulating neuronal apoptosis.  In: Neurotraumatology:  Biomechanic Aspects, Cytologic and Molecular Mechanisms.  Schmidt-Römhild, Lübeck, pp. 107-120, 1997.

A.I. FADEN. Iatrogenic illness:  an overview with particular reference to neurologic complications.  In:   Neurologic Clinics.  W.B. Saunders Company:  Philadelphia, Vol. 16(1), pp. 1-8, 1998.

Temple M, O'Leary D, and Faden A.  The role of glutamate receptors in the pathophysiology of traumatic brain injury.  In:  Head Trauma, L. Miller, R. Hayes, and J. Newcomb, Eds. New York: John Wiley & Sons, 2001; pp. 87-113.

Cernak I, Lea PM, and FADEN AI.  Neurological disorders – epidemiology, clinical overview, and model systems: Brain trauma.  In:  Neuroprotection – Models, Mechanisms, Therapies (M. Bahr, ed.), Wiley-VCH Verlag GmbH&Co.  KGaA, Weinheim, 2004, pp. 95-127.

Knoblach, S., FADEN, AI.  Proteases in Traumatic Brain Injury.  In:  Proteases in Biology and Disease, Springer Science + Business Media, Inc., 2004, pp. 79-108.

Stoica B, FADEN AI. Programmed Neuronal Cell Death Mechanisms in CNS Injury. In: Acute Neuronal Injury: The Role of Excitottoxic Cell Death Mechanisms (DG Fujjikawa ed). Springer Science and Business Media, LLC, 2010, pp169-199.